Champions Oncology Stock Probability of Future Stock Price Finishing Over 17.61

CSBR Stock  USD 9.58  0.56  5.52%   
Champions Oncology's future price is the expected price of Champions Oncology instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Champions Oncology performance during a given time horizon utilizing its historical volatility. Check out Champions Oncology Backtesting, Champions Oncology Valuation, Champions Oncology Correlation, Champions Oncology Hype Analysis, Champions Oncology Volatility, Champions Oncology History as well as Champions Oncology Performance.
To learn how to invest in Champions Stock, please use our How to Invest in Champions Oncology guide.
  
Please specify Champions Oncology's target price for which you would like Champions Oncology odds to be computed.

Champions Oncology Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Champions Oncology for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Champions Oncology can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Champions Oncology had very high historical volatility over the last 90 days
The company reported the previous year's revenue of 50.16 M. Net Loss for the year was (7.28 M) with profit before overhead, payroll, taxes, and interest of 30.22 M.
Champions Oncology currently holds about 8.06 M in cash with (6.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.6.
Roughly 26.0% of the company shares are held by company insiders

Champions Oncology Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Champions Stock often depends not only on the future outlook of the current and potential Champions Oncology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Champions Oncology's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding13.5 M
Cash And Short Term Investments2.6 M

Champions Oncology Technical Analysis

Champions Oncology's future price can be derived by breaking down and analyzing its technical indicators over time. Champions Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Champions Oncology. In general, you should focus on analyzing Champions Stock price patterns and their correlations with different microeconomic environments and drivers.

Champions Oncology Predictive Forecast Models

Champions Oncology's time-series forecasting models is one of many Champions Oncology's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Champions Oncology's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Champions Oncology

Checking the ongoing alerts about Champions Oncology for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Champions Oncology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Champions Oncology had very high historical volatility over the last 90 days
The company reported the previous year's revenue of 50.16 M. Net Loss for the year was (7.28 M) with profit before overhead, payroll, taxes, and interest of 30.22 M.
Champions Oncology currently holds about 8.06 M in cash with (6.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.6.
Roughly 26.0% of the company shares are held by company insiders

Additional Tools for Champions Stock Analysis

When running Champions Oncology's price analysis, check to measure Champions Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Champions Oncology is operating at the current time. Most of Champions Oncology's value examination focuses on studying past and present price action to predict the probability of Champions Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Champions Oncology's price. Additionally, you may evaluate how the addition of Champions Oncology to your portfolios can decrease your overall portfolio volatility.